Recursion Pharmaceuticals Inc (RXRX)
9.51
-0.50
(-5.00%)
USD |
NASDAQ |
May 16, 16:00
9.51
0.00 (0.00%)
After-Hours: 06:35
Recursion Pharmaceuticals Total Long Term Debt (Quarterly): 1.126M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.126M |
| December 31, 2023 | 1.142M |
| September 30, 2023 | 1.821M |
| June 30, 2023 | 1.831M |
| March 31, 2023 | 1.84M |
| December 31, 2022 | 0.633M |
| September 30, 2022 | 0.656M |
| June 30, 2022 | 0.679M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.702M |
| December 31, 2021 | 0.723M |
| September 30, 2021 | 0.744M |
| June 30, 2021 | 12.56M |
| March 31, 2021 | 12.48M |
| December 31, 2020 | 12.49M |
| September 30, 2020 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2020
12.56M
Maximum
Jun 2021
3.295M
Average
1.126M
Median
Mar 2024
Total Long Term Debt (Quarterly) Benchmarks
| Eli Lilly and Co | 26.21B |
| Absci Corp | 7.046M |
| Palatin Technologies Inc | 0.00 |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |